Outside the box: scale up your ambitions with a Guardtech Cleanrooms modular
The Guardtech Group’s modular champions are offering flexible solutions that grow and adapt alongside their clients’ aspirations.
Celebrating our Centres - Leicester
This week we spoke to the team at the NIHR BioResource Centre Leicester about community engagement events at supermarkets to promote participation in research. In tandem, we also learn about Leicester’s very own NHS Trust Chief Executive, who has made a personal commitment to health research, recently joining the NIHR BioResource.
Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics
Cardiff, UK and Massachusetts, US - Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering company developing methods to engineer improved and more developable therapeutic antibodies, announces they will be extending their collaboration to advance immune checkpoint inhibitors in…
Cam AI is offering free CBT sessions for 18-24 years olds
Cam AI writes...
Suffering with anxiety and struggling to get support? Cam AI, a mental health startup, is offering volunteers free Cognitive Behavioural Therapy sessions for anxiety with our accredited therapists*.
Get that 'Movie' experience in a meeting
Making the meeting room experience one step better with AI directed cameras to make sure everything is captured in the room, not just the speaker.
Astex CSO David Rees Honoured as a Hero of Chemistry by the American Chemical Society
Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, congratulates its Chief Scientific Officer (CSO), David Rees PhD, FMedSci, FRSC on being honoured by the American Chemical Society (ACS) Heroes of Chemistry
New event launches - Achieving Net Zero: a toolkit for businesses
Join us for an event on November 8 at St John's Innovation Centre that will help your business achieve its Net Zero ambitions.
Major conference wins for Cambridge
Meet Cambridge, the official conference and events bureau for Cambridge and the surrounding area, has announced a series of major conference wins which will bring approximately 2,700 delegates to Cambridge, worth an estimated value of £2.3mn to the local economy.
Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer
London, UK - Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, announces that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO).
Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy
Cambridge, UK - Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.
Undiagnosed breathing conditions could cause winter NHS crisis
electronRx writes...
How to tackle antimicrobial resistance using diagnostics
Growing up as a child, I thought that antibiotics were the magical answer for most medical issues, be that a persistent sore throat or a high fever.
Seaweed to food - protein research company BravelyCultured moves into The Epicentre, Haverhill
BraveleyCultured, a bio-tech company that is looking to use marine micro-organisms mainly in the foodtech sector, is the latest to take laboratory desk space at The EpiCentre in Haverhill.
FirstStage - a VR creative toolkit
The FirstStage VR toolkit is a collaborative virtual production tool that is applicable across multiple industries.
Bio-Rad extends range of anti-idiotypic antibodies for use in preclinical and clinical drug development
Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring.
FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Maja Pedersen as Chief Quality Officer
Hillerød, Denmark – FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen announces a new strategic leadership appointment to support the company through its next growth phase.
Group B Streptococcus vaccines - not just for the baby
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global demand assessment for Group B Streptococcus (GBS) vaccines.
electronRx shares views on lack of health research hindering public support for clean air schemes
The recent extension of the London ULEZ zone has been contentious with much public backlash to its introduction earlier this year.
The public see this as a direct impact to them as opposed to understanding the benefits to their ongoing health and wellbeing.
Evonetix places first DNA synthesis development platform at Imperial College London
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization
Happy 3rd Birthday to The Eating Disorders Genetics Initiative (EDGI) UK!
The Eating Disorders Genetics Initiative in the UK (EDGI UK) was launched 3 years ago, recruiting members of the public who have experienced any eating disorder. We spoke to the team to find out what's happened since the launch in 2020, achievements to date, who they've collaborated with and how you can take part.
Delivering excellence for our clients – Team Consulting appoints new CEO
Iain Ansell has recently taken on the role of CEO at Team Consulting.
Back Care Awareness Week
This week is Back Care Awareness Week - a campaign raising awareness of back pain, which is one of the most common musculoskeletal problems.
Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows
Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions.
Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies
Dundee, UK: Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, announces it is supporting a PhD student in the Institute of Chemical Biology EPSRC Centre for Doctoral Training (CDT) in Chemical Biology, at Imperial College London.
Guardtech Group: the growing family business with global aspirations
Cleanroom construction specialists determined to retain their family values as individual brands continue to thrive in UK and beyond